Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Scientists Search For Sleepless Souls Suffering Lifelong Insomnia, Scotland
Most people have experienced the odd sleepless night before a crucial exam, a job interview or before going on holiday, but few people get by with just a couple of hours of sleep a day, every day.
generic viagra online
High-Tech 'Smart' Face Mask Helps Hong Kong Families Combat Swine Flu
Beginning today, Hong Kong people and their children will have direct access to Filligent"s patented anti- microbial face mask, the BioMask(TM). The revolutionary mask, which traps and kills germs like H1N1 upon contact, was launched at Asia"s leading drugstore chain, Watsons, today. In addition, Hong Kong"s biggest travel agency, Hong Thai, will be providing the BioMask(TM), on a complimentary basis, to all air travelers through the end of August. Up until now, the CE-certified, specialist mask has only been available to medical and healthcare professionals. The launch and availability of the BioMask(TM) in consumer retailers and service providers is significant because, as CEO Melissa Mowbray-d"Arbela says, "The BioMask(TM) is the first "intelligent" face mask. You don"t have to be a health care worker or medical professional to use it correctly. Instead, the mask is very easy to put on, wear and dispose of properly. Thus, it"s one of the best forms of protection for ordinary people and their children during this year"s swine flu crisis."
News of the day
First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University Of Wisconsin Riverview Cancer Center
Earlier this month the University of Wisconsin Cancer Center Riverview became the first medical facility in the world to treat patients with a breakthrough treatment of skin cancer. Located within Riverview Hospital, Wisconsin Rapids, the UW Cancer Center Riverview is the first to treat skin cancer patients with the FDA-cleared Axxent(R) Electronic Brachytherapy System from Xoft, Inc. Electronic Brachytherapy, eBx(TM) , delivers a high therapeutic dose to a cancer tumor while sparing nearby normal tissue by using a miniaturized X-ray rather than radioactive isotopes.
Cardiovascular

Retroperitoneal Lymph Node Dissection In Patients With High Risk Testicular Cancer

UroToday.com - We performed a retrospective review of retroperitoneal lymph node dissection (RPLND) patients with high risk features (>30% embryonal carcinoma, with or without lymphovascular invasion) and compared primary (P-RPLND) versus post-chemotherapy (PC-RPLND) patients. The average percent embryonal carcinoma between P-RPLND vs. PC-RPLND was 75.3 vs. 71.2%, respectively. The average LVI between P-RPLND vs. PC-RPLND was 53.4 vs. 61.4%, respectively. Regarding pathologic stage II (PS II) disease, there were 37 (49%) and 35 (61%) cases, respectively. Only 2 (3%) of patients who underwent P-RPLND were noted to have systemic disease outside the retroperitoneum (metastasis to the lung and mesentery each). Overall, there were 6 (8%) and 5 (9%) recurrences between the P-RPLND and PC-RPLND groups all within 2 years of surgery. P-RPLND offered less blood loss, shorter operative time and fewer complications than PC-RPLND. Our findings highlight that P-RPLND can spare a majority of these high risk patients the potential long-term toxicity of chemotherapy compounded by radiation exposure from surveillance imaging. Written by Stephen Williams, MD as part of Beyond the Abstract on UroToday.com UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com Copyright © 2009 - UroToday


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009